Showing results (11-20 of 171) with videos related to
Sort By:
Pageof 18
Cancer Research|November 1, 1981
Species difference in N-hydroxylation of a tryptophan pyrolysis product in relation to mutagenic activationY Yamazoe, T Kamataki, R KatoXenobiotica; the Fate of Foreign Compounds in Biological Systems|September 1, 1992
Polymorphism in stereoselective hydroxylations of mephenytoin and hexobarbital by Japanese liver samples in relation to cytochrome P-450 human-2 (IIC9)R Kato, Y Yamazoe, T YasumoriBritish Journal of Clinical Pharmacology|February 15, 2000
Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juiceW Tassaneeyakul, S Vannaprasaht, Y YamazoeEnvironmental Health Perspectives|March 1, 1983
N-hydroxylation of carcinogenic and mutagenic aromatic aminesR Kato, T Kamataki, Y YamazoeMutation Research|August 1, 1982
Metabolic activation of 2-amino-9H-pyrido[2,3-b]indole by rat-liver microsomesT Niwa, Y Yamazoe, R KatoPrincess Takamatsu Symposia|January 1, 1990
Pharmacogenetics and polymorphism of human P-450 which activates and detoxicates xenobiotics and carcinogensR Kato, Y Yamazoe, T YasumoriJournal of Biochemistry|May 1, 1991
Cytochrome P-450 human-2 (P-450IIC9) in mephenytoin hydroxylation polymorphism in human livers: differences in substrate and stereoselectivities among microheterogeneous P-450IIC species expressed in yeastsT Yasumori, Y Yamazoe, R KatoCarcinogenesis|August 1, 1992
Sulfotransferase-mediated DNA binding of N-hydroxyarylamines(amide) in liver cytosols from human and experimental animalsM Abu-Zeid, Y Yamazoe, R KatoSkin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1990
High capacity of human skin for N-acetylation of arylaminesY Kawakubo, Y Yamazoe, R Kato, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1981
Structural elucidation of a mutagenic metabolite of 3-amino-1-methyl-5H-pyrido[4,3-b]indoleY Yamazoe, K Ishii, T Kamataki, et al.Pageof 18